BGI Genomics Co., Ltd. (SHE: 300676)
China
· Delayed Price · Currency is CNY 35.56
+0.76 (2.18%)
Sep 9, 2024, 1:43 PM CST
BGI Genomics Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 6, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 13,542 | 19,676 | 21,188 | 35,990 | 50,923 | 27,487 | Upgrade
|
| Market Cap Growth | -45.71% | -7.14% | -41.13% | -29.32% | 85.26% | 14.50% | Upgrade
|
| Enterprise Value | 9,190 | 14,568 | 14,557 | 28,800 | 47,594 | 26,739 | Upgrade
|
| Last Close Price | 35.51 | 47.86 | 50.67 | 85.65 | 125.02 | 66.77 | Upgrade
|
| PE Ratio | 241.67 | 212.44 | 25.90 | 24.12 | 23.86 | 96.67 | Upgrade
|
| PS Ratio | 3.55 | 4.52 | 3.00 | 5.32 | 6.06 | 9.82 | Upgrade
|
| PB Ratio | 1.53 | 1.97 | 2.07 | 3.81 | 8.45 | 6.25 | Upgrade
|
| P/FCF Ratio | -22.86 | -23.77 | -18.66 | 17.20 | 15.42 | -68.34 | Upgrade
|
| P/OCF Ratio | 40.96 | 48.13 | 161.89 | 14.53 | 14.13 | 122.57 | Upgrade
|
| EV/Sales Ratio | 2.21 | 3.35 | 2.06 | 4.26 | 5.67 | 9.55 | Upgrade
|
| EV/EBITDA Ratio | 18.49 | 31.35 | 11.53 | 14.70 | 16.16 | 53.62 | Upgrade
|
| EV/EBIT Ratio | 130.69 | 128.98 | 16.08 | 17.14 | 18.01 | 103.80 | Upgrade
|
| EV/FCF Ratio | -15.74 | -17.60 | -12.82 | 13.76 | 14.42 | -66.48 | Upgrade
|
| Debt / Equity Ratio | 0.04 | 0.04 | 0.02 | 0.09 | 0.22 | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | 0.90 | 0.69 | 0.15 | 0.41 | 0.45 | 0.13 | Upgrade
|
| Debt / FCF Ratio | -0.76 | -0.44 | -0.18 | 0.41 | 0.40 | -0.16 | Upgrade
|
| Asset Turnover | 0.31 | 0.31 | 0.49 | 0.53 | 0.98 | 0.50 | Upgrade
|
| Inventory Turnover | 3.41 | 3.34 | 4.42 | 3.01 | 5.00 | 4.45 | Upgrade
|
| Quick Ratio | 2.41 | 2.12 | 2.22 | 2.94 | 1.87 | 2.25 | Upgrade
|
| Current Ratio | 2.74 | 2.41 | 2.47 | 3.26 | 2.21 | 2.82 | Upgrade
|
| Return on Equity (ROE) | 0.63% | 0.93% | 8.23% | 19.11% | 40.32% | 6.44% | Upgrade
|
| Return on Assets (ROA) | 0.33% | 0.50% | 3.95% | 8.25% | 19.32% | 2.88% | Upgrade
|
| Return on Capital (ROIC) | 0.42% | 0.68% | 5.46% | 11.91% | 27.97% | 3.69% | Upgrade
|
| Earnings Yield | 0.41% | 0.47% | 3.79% | 4.06% | 4.10% | 1.01% | Upgrade
|
| FCF Yield | -4.31% | -4.21% | -5.36% | 5.81% | 6.48% | -1.46% | Upgrade
|
| Dividend Yield | 0.29% | 0.21% | 1.97% | 0.41% | 0.28% | 0.15% | Upgrade
|
| Payout Ratio | 10.08% | 448.58% | 20.82% | 12.16% | 2.98% | 14.48% | Upgrade
|
| Buyback Yield / Dilution | -1.54% | -0.48% | 0.32% | -3.11% | 0.20% | 0.00% | Upgrade
|
| Total Shareholder Return | -1.25% | -0.27% | 2.29% | -2.70% | 0.48% | 0.15% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.